Roche’s Genetech Offer: The Rules of Engagement

Swiss drug giant Roche is offering $89 dollars a share for the 44% of Genentech it doesn’t own already, as you may have heard by now. The offer price is about 9% more than Genentech’s Friday close and represents a pretty thin premium compared with those paid by other drugmakers for lesser biotech companies. Genentech [...]